Akorn Inc (AKRXQ) Gross Profit Margin starting from the second quarter 2020 to second quarter 2019, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Akorn Inc  (AKRXQ)


Akorn Inc's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AKRXQ Gross Profit Margin (Jun 30 2020)
Q2 		(Mar 31 2020)
Q1 		(Dec 31 2019)
Q4 		(Sep 30 2019)
Q3 		(Jun 30 2019)
Q2
Y / Y Revenue Change -32.43 %
Seq. Revenue Change -41.22 %
Revenue In Millions $120.31
Gross Profit Margin 25.81 %
Gross Profit Margin Total Ranking # 2867
Gross Profit In Millions $31.05
Y / Y Gross Profit Change -54.32 %
Seq. Gross Profit Change -67.16 %


Commenting Second Quarter 2020 Gross Profit Margin
Akorn Inc experienced contraction in Gross Profit by -67.16 % to $120 millions and Revenue by -41.22 %, while Gross Profit Margin fell to 25.81 %, below company*s average Gross Profit Margin.


Observing second quarter 2020 results within Major Pharmaceutical Preparations industry 146 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from 1750 to 2867.
Learn about Gross Margin
AKRXQ's Gross Profit Margin second quarter 2020 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 147
Healthcare Sector # 425
Overall # 2791

Gross Profit Margin Statistics
High Average Low
63.48 % 49.9 % 16.46 %
(Sep 30 2015)   (Dec 31 2018)


AKRXQ Gross Income Trends • More of AKRXQ's Profitabilty Ratios • AKRXQ Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
AKRXQ's Cumulative Gross Profit Margin
Major Pharmaceutical Preparations Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
AKRXQ's Gross Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for AKRXQ's Competitors
Gross Profit Margin Profit Margin for Akorn Inc's Suppliers
Gross Profit Margin Profit Margin for AKRXQ's Customers

You may also want to know
AKRXQ's Annual Growth Rates AKRXQ's Profitability Ratios AKRXQ's Asset Turnover Ratio AKRXQ's Dividend Growth
AKRXQ's Roe AKRXQ's Valuation Ratios AKRXQ's Financial Strength Ratios AKRXQ's Gross Profit Growth
AKRXQ's Roa AKRXQ's Inventory Turnover Ratio AKRXQ's Growth Rates AKRXQ's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Jun 30 2020, within Major Pharmaceutical Preparations Industry Gross Profit MarginJun 30 2020 MRQ Gross ProfitJun 30 2020 MRQ Revenue
Organogenesis Holdings Inc   70.94 %$ 48.918  Millions$ 68.960  Millions
Zoetis Inc   70.87 %$ 1,097.000  Millions$ 1,548.000  Millions
Pacira Biosciences inc   70.46 %$ 53.200  Millions$ 75.505  Millions
Aytu Biopharma Inc  69.23 %$ 10.288  Millions$ 14.861  Millions
Biohaven Ltd   68.47 %$ 6.640  Millions$ 9.698  Millions
Lexaria Bioscience Corp   68.15 %$ 0.061  Millions$ 0.090  Millions
Avadel Pharmaceuticals Plc  67.45 %$ 6.806  Millions$ 10.091  Millions
Jaguar Health Inc   67.45 %$ 2.136  Millions$ 3.167  Millions
Emergent Biosolutions Inc   67.11 %$ 264.900  Millions$ 394.700  Millions
Fortress Biotech Inc   66.97 %$ 6.333  Millions$ 9.457  Millions
Sunshine Biopharma Inc   65.92 %$ 0.010  Millions$ 0.015  Millions
Amag Pharmaceuticals inc   65.54 %$ 34.575  Millions$ 52.755  Millions
Flexion Therapeutics Inc   64.53 %$ 9.970  Millions$ 15.451  Millions
Abbvie Inc   64.40 %$ 6,714.000  Millions$ 10,425.000  Millions
Johnson and Johnson  64.12 %$ 11,757.000  Millions$ 18,336.000  Millions
Veru Inc   63.16 %$ 6.519  Millions$ 10.322  Millions
Petros Pharmaceuticals inc   60.74 %$ 0.834  Millions$ 1.374  Millions
International Stem Cell Corporation  60.32 %$ 1.093  Millions$ 1.812  Millions
Heron Therapeutics Inc   60.27 %$ 13.663  Millions$ 22.668  Millions
Harrow Inc   60.25 %$ 4.856  Millions$ 8.060  Millions
Therapeuticsmd Inc   58.88 %$ 6.301  Millions$ 10.701  Millions
Schrodinger Inc   58.82 %$ 13.583  Millions$ 23.092  Millions
Epizyme Inc.  58.57 %$ 1.445  Millions$ 2.467  Millions
Prestige Consumer Healthcare Inc   58.36 %$ 133.868  Millions$ 229.394  Millions
Ani Pharmaceuticals Inc  57.30 %$ 27.775  Millions$ 48.470  Millions
China Health Industries Holdings Inc   55.96 %$ 1.137  Millions$ 2.032  Millions
Abbott Laboratories  55.47 %$ 4,065.000  Millions$ 7,328.000  Millions
Neos Therapeutics Inc   55.24 %$ 7.255  Millions$ 13.133  Millions
Cryoport inc   54.61 %$ 5.127  Millions$ 9.389  Millions
Talphera Inc   53.15 %$ 1.554  Millions$ 2.924  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.